News sentiment analysis powered by sentiment-insight.com
2023-11-14
positive
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript
Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow.
2023-05-11
negative
Acorda: Q1 Earnings Snapshot
Acorda Therapeutics Inc. (ACOR) on Thursday reported a loss of $16.8 million in its first quarter. On a per-share basis, the Pearl River, New York-based company said it had a lost of 69 cents. The drugmaker posted revenue of $22.3 million in the period.
2023-05-11
negative
Acorda: Q1 Earnings Snapshot
Acorda Therapeutics Inc. (ACOR) on Thursday reported a loss of $16.8 million in its first quarter. On a per-share basis, the Pearl River, New York-based company said it had a lost of 69 cents. In the final minutes of trading on Thursday, the company's shares hit 84 cents.
2023-03-09
positive
Acorda: Q4 Earnings Snapshot
Acorda Therapeutics Inc. (ACOR) reported fourth-quarter net income of $19.1 million. The Pearl River, New York-based company said it had revenue of $31.5 million. For the year, the company reported that its loss narrowed to $65.9 million.
2023-03-09
positive
Acorda: Q4 Earnings Snapshot
Acorda Therapeutics Inc. (ACOR) on Thursday reported fourth-quarter net income of $19.1 million. The Pearl River, New York-based company posted revenue of $31.5 million in the period. For the year, the company reported that its loss narrowed to $65.9 million.
2023-03-09
positive
Acorda: Q4 Earnings Snapshot
Acorda Therapeutics Inc. (ACOR) reported fourth-quarter net income of $19.1 million. The Pearl River, New York-based company reported revenue of $31.5 million. For the year, the company reported that its loss narrowed to $65.9 million.
Sign Up
